share_log

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts

Expert Outlook: Evolent Health Through The Eyes Of 7 Analysts

專家展望:evolent health在7位分析師眼中
Benzinga ·  10/08 23:00
In the latest quarter, 7 analysts provided ratings for Evolent Health (NYSE:EVH), showcasing a mix of bullish and bearish perspectives.
在最新的季度裏,有7位分析師就Evolent Health (紐交所:EVH) 進行了評級,展現了看好和看淡的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估,下表展示了過去30天內不斷變化的情緒,並將其與之前的幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Evolent Health, presenting an average target of $38.29, a high estimate of $45.00, and a low estimate of $31.00. Witnessing a positive shift, the current average has risen by 4.3% from the previous average price target of $36.71.
在12個月價格目標的評估中,分析師揭示了 evolent health 的見解,提出了38.29美元的平均目標,45.00美元的高估值和31.00美元的低估值。目前的平均價格已經比上一個36.71美元的平均價格目標上升了4.3%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細剖析
In examining recent analyst actions, we gain insights...
通過審查最近分析...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論